These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 3869115

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [In vitro effects of cefotetan against Bacteroides of the fragilis group].
    Privitera G, Ortisi G, Rossi R, Vigo B.
    G Ital Chemioter; 1985; 32(2):371-4. PubMed ID: 3869116
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro antibacterial activity of cefotetan against Bacteroides fragilis group clinical isolates.
    Menozzi M, Avanzini P, Lecchini R, Bigi M, Chezzi C.
    Chemioterapia; 1987 Jun; 6(2 Suppl):88-91. PubMed ID: 3509541
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A multicenter study of the in vitro antianaerobic activity of cefotetan compared with other antimicrobial agents.
    Zabransky RJ, Bobey DG, Sheikh W.
    Am J Surg; 1988 May 31; 155(5A):47-51. PubMed ID: 3163901
    [Abstract] [Full Text] [Related]

  • 10. Antibacterial activity of the cephamycin cefotetan: an in-vitro comparison with other beta-lactam antibiotics.
    Clarke AM, Zemcov SJ.
    J Antimicrob Chemother; 1983 Jan 31; 11 Suppl():67-72. PubMed ID: 6404881
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of Bacteroides fragilis, Bacteroides thetaiotaomicron, and Fusobacteria in Antibacterial agents.
    Niederau W, Höffler U, Pulverer G.
    Arzneimittelforschung; 1980 Jan 31; 30(12):2093-8. PubMed ID: 7194067
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of cefotetan compared with that of other antimicrobial agents against anaerobic bacteria.
    Wexler HM, Finegold SM.
    Antimicrob Agents Chemother; 1988 Apr 31; 32(4):601-4. PubMed ID: 3163908
    [Abstract] [Full Text] [Related]

  • 13. [Moxalactam: preclinical evaluation].
    Chabbert YA.
    Sem Hop; 1983 Jun 30; 59(26):1943-6. PubMed ID: 6310782
    [No Abstract] [Full Text] [Related]

  • 14. Susceptibility of cefotetan and Sch 34343 to beta-lactamases produced by strains of Bacteroides that hydrolyse cefoxitin or imipenem.
    Andrew JH, Greenwood D.
    J Antimicrob Chemother; 1987 May 30; 19(5):591-5. PubMed ID: 3497146
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility testing of anaerobic bacteria.
    Citron D.
    Am J Med Technol; 1983 Nov 30; 49(11):769-72. PubMed ID: 6316785
    [No Abstract] [Full Text] [Related]

  • 16. Activity in vitro of cefotetan against non-sporing anaerobes: a comparative study.
    Ruckdeschel G.
    J Antimicrob Chemother; 1983 Jan 30; 11 Suppl():117-24. PubMed ID: 6573312
    [No Abstract] [Full Text] [Related]

  • 17. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
    Sofianou D, Douboyas J, Papapanagiotou J, Paradelis AG.
    Methods Find Exp Clin Pharmacol; 1982 Jan 30; 4(3):173-7. PubMed ID: 7121128
    [Abstract] [Full Text] [Related]

  • 18. National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000.
    Snydman DR, Jacobus NV, McDermott LA, Ruthazer R, Goldstein EJ, Finegold SM, Harrell LJ, Hecht DW, Jenkins SG, Pierson C, Venezia R, Rihs J, Gorbach SL.
    Clin Infect Dis; 2002 Sep 01; 35(Suppl 1):S126-34. PubMed ID: 12173121
    [Abstract] [Full Text] [Related]

  • 19. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
    Watt B, Naden MG.
    J Chemother; 1989 Jul 01; 1(4 Suppl):106-7. PubMed ID: 16312326
    [No Abstract] [Full Text] [Related]

  • 20. Cefotetan activity against Gram-negative aerobes and anaerobes.
    Moosdeen F, Maskell J, Philpott-Howard J, Williams JD.
    J Antimicrob Chemother; 1983 Jan 01; 11 Suppl():59-65. PubMed ID: 6601657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.